RISK OF HEPATOTOXICITY
See full prescribing information for complete boxed warning.
- TRADE NAME: Juxtapid (Aegerion)
- INDICATIONS: Homozygous familial hypercholesterolemia
- CLASS: Lipid regulator
- HALF-LIFE: 39.7 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Bile acid sequestrants, Boceprevir, Clarithromycin, Conivaptan, Grapefruit Juice, Indinavir, Itraconazole, Ketoconazole, Lopinavir, Lovastatin, Mibefradil, Nefazodone, Nelfinavir, Oral Contraceptives, P-glycoprotein substrates, Posaconazole, Ritonavir, Saquinavir, Simvastatin, Strong or moderate CYP3A4 inhibitors, Telaprevir, Telithromycin, Viloxazine, Voriconazole, Warfarin
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of lomitapide in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 03/01/2024
